CPhI's Conference on Bioequivalence and Bioavailability Studies to Bring Together Senior Delegates From Pharma Companies and CROs

Oct 23, 2012, 05:29 ET from UBM India Pvt. Ltd.

MUMBAI, October 23, 2012 /PRNewswire/ --

CPhI India is glad to announce its inaugural conference on Bioequivalence and Bioavailability Studies, taking place from 5-7 December, in Mumbai, India. This focused event consists of a two-day strategic conference which will address the most critical, technical and commercial challenges of BA/BE, clinical research, regulatory, formulations and bioanalytical professionals. This event also includes an exclusive workshop on scientific challenges and regulatory framework in bioanalytical science.

This event has generated a lot of interest as it has a blend of technical and commercial topics for pharma companies as well as CROs. Some of the key industry leaders confirmed include Alfred Elvin, President, Anatese Biopharmaceutic USA; Indu Bhushan, Senior Vice President and Head - Formulations (R&D), Mylan Laboratories; Rajeev Raghuvanshi, Vice President, Differentiated Formulations R&D, Dr. Reddy's Laboratories; Apurva Shah, Co-founder and Group Managing Director, Veeda Clinical Research and Chairman, ACRO India and many more.

Featuring in-depth discussions on clinical research, study design, volunteer selection, quality, regulatory and bioanalytical method development in BA/BE studies, this event promises to provide complete knowledge for compliance with global regulatory standards. The workshop is designed specifically to gain adequate understanding of the current international regulations and sound scientific strategies for method development, validation, sample analysis, day-to-day documentation and data management. Visit http://www.bioavailability-bioequivalence.com/pr for more information.

About CPhI:

CPhI India is the largest and most important meeting place for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian pharma industry.

About UBM India:

UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details, please visit the UBM India website, http://www.ubmindia.in.

Primary Media Contact: Shwetha Prabhu, shwetha.prabhu@ubm.com, 91-22-4046 1466

SOURCE UBM India Pvt. Ltd.